Related Experiment Video
Updated: Feb 16, 2026

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
Published on: February 25, 2016
Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm
Suparna C Clasen1, Bonnie Ky1,2, Rupal O'Quinn1
1Cardio-oncology in the Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Fluoropyrimidine chemotherapy can cause coronary vasospasm, but a new protocol allows patients to safely restart treatment. This approach successfully completed chemotherapy for all 11 patients without cardiac events.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Background:
- Fluoropyrimidines (5-FU, capecitabine) are vital chemotherapy agents for solid tumors.
- Cardiac toxicity, including coronary vasospasm and myocardial ischemia, limits their use.
- Patients often interrupt chemotherapy after experiencing cardiovascular side effects.
Purpose of the Study:
- To evaluate the safety and efficacy of rechallenging patients with fluoropyrimidines after suspected drug-induced coronary vasospasm.
- To assess the feasibility of completing planned chemotherapy regimens in patients with a history of fluoropyrimidine-associated cardiac events.
Main Methods:
- A case series of 11 patients with suspected fluoropyrimidine-induced coronary vasospasm was analyzed.
- Patients were rechallenged with intravenous fluoropyrimidine or oral capecitabine.
- A cardioprotective protocol involving calcium channel blockers and long-acting nitrates was administered prior to rechallenge.
Main Results:
- All 11 patients successfully completed their planned first-line chemotherapy regimens with minimal interruption.
- No cardiac events or recurrent coronary vasospasm were observed during or after therapy.
- Prophylactic cardiac medications were discontinued upon completion of chemotherapy.
Conclusions:
- Rechallenging patients with fluoropyrimidines using a protocol of careful cardiac monitoring and combined calcium channel blockers and long-acting nitrates is feasible and safe.
- This strategy allows for the continuation of potentially curative chemotherapy regimens.
- Further research is warranted to validate this approach in a broader patient population.
Related Concept Videos
Electrical Current
Toxicity Testing in Animals
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Overview
Bioactivation and Tissue Toxicity
Current Density

